These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4564745)

  • 1. Report on a double-blind investigation into the influence of -pyridyl-carbinol on the cholesterol level of the blood.
    Nelemans FA
    Arzneimittelforschung; 1972 Aug; 22(8):1410-3. PubMed ID: 4564745
    [No Abstract]   [Full Text] [Related]  

  • 2. Biphenabid (Probucol): a new hypocholesterolemic agent.
    Kalams Z; Dacquisto M; Kornett GS
    Curr Ther Res Clin Exp; 1971 Nov; 13(11):692-4. PubMed ID: 5000716
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical evaluation of the therapeutic activity of the -pyridyl-carbinol ester of clofibric acid].
    Silingardi V; Renzi R; Mora A; Di Prisco AU
    Minerva Med; 1973 Mar; 64(16):751-69. PubMed ID: 4704721
    [No Abstract]   [Full Text] [Related]  

  • 4. High-molecular-weight hydroxypropylmethylcellulose. A cholesterol-lowering agent.
    Dressman JB; Adair CH; Barnett JL; Berardi RR; Dunn-Kucharski VA; Jarvenpaa KM; Parr DD; Sowle CA; Swidan SZ; Tobey SW
    Arch Intern Med; 1993 Jun; 153(11):1345-53. PubMed ID: 8507125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan decreases total cholesterol in women: a randomized, double-blind, placebo-controlled trial.
    Bokura H; Kobayashi S
    Eur J Clin Nutr; 2003 May; 57(5):721-5. PubMed ID: 12771974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled clinical trial of a new bile acid-sequestering resin, colestipol, in the treatment of hypercholesterolaemia.
    Miller NE; Clifton-Bligh P; Nestel PJ; Whyte HM
    Med J Aust; 1973 Jun; 1(25):1223-7. PubMed ID: 4579666
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cholesterol resorption inhibition prevents high statin doses. Lipid lowering in double-pack].
    MMW Fortschr Med; 2002 Nov; 144(48):60. PubMed ID: 12532550
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
    Feldman T; Davidson M; Shah A; Maccubbin D; Meehan A; Zakson M; Tribble D; Veltri E; Mitchel Y
    Clin Ther; 2006 Jun; 28(6):849-59. PubMed ID: 16860168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Can cholesterol lowering treatment have unwanted effects?].
    Karpe F; Regnström J; Tornvall P
    Lakartidningen; 1991 May; 88(18):1670-1. PubMed ID: 2041411
    [No Abstract]   [Full Text] [Related]  

  • 10. [The cholesterol question. Disinformed information].
    Bobbio M; Brusca A
    G Ital Cardiol; 1991 Sep; 21(9):1029-33. PubMed ID: 1790828
    [No Abstract]   [Full Text] [Related]  

  • 11. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
    Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E;
    Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk patients are often insufficiently treated. LDL cholesterol to be held down even more vigorously].
    MMW Fortschr Med; 2004 Oct; 146(44):56-7. PubMed ID: 15566253
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of parachlorophenoxyisobutyric acid (CPIB acid) and of diet on blood cholesterol and on the beta-alpha lipoprotein ratio in aged subjects].
    Bronzini A; Di Gregorio D; Scotti G
    G Gerontol; 1969 Nov; 17(11):1067-75. PubMed ID: 5397791
    [No Abstract]   [Full Text] [Related]  

  • 14. Practical possibilities for lowering serum cholesterol. Results of a double-blind study.
    Nelemans FA
    Nutr Metab; 1973; 15(1):151-3. PubMed ID: 4576165
    [No Abstract]   [Full Text] [Related]  

  • 15. A statin in every medicine cabinet?
    Walsh MN
    Health News; 2002 Sep; 8(9):3. PubMed ID: 12229899
    [No Abstract]   [Full Text] [Related]  

  • 16. Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption.
    Bruckert E; Giral P; Tellier P
    Circulation; 2003 Jul; 107(25):3124-8. PubMed ID: 12835406
    [No Abstract]   [Full Text] [Related]  

  • 17. Heartsick America.
    Cowley G
    Newsweek; 2001 May; 137(22):43. PubMed ID: 11393041
    [No Abstract]   [Full Text] [Related]  

  • 18. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Increased autoaggression caused by cholesterol lowering drugs?].
    Richter WO
    Fortschr Med; 1994 Dec; 112(35-36):507-8. PubMed ID: 7843681
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of a chronic therapy with the pineal hormone melatonin on cholesterol levels in idiopathic hypercholesterolemic patients.
    Pittalis S; Lissoni P; Giani L; Casati M; Kropacek N; Orfanò S; Giavolucci F; Merlini D
    Recenti Prog Med; 1997 Sep; 88(9):401-2. PubMed ID: 9323901
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.